Quick Answer
PALISADE BIO, INC. reported Total Revenue of $0.00 for fiscal year 2024.
PALISADE BIO, INC. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2024 | $0.00 | -100.0% |
| 2023 | $250.0K | — |
| 2022 | $0.00 | -100.0% |
| 2017 | $260.0K | +1500.4% |
| 2016 | $16.2K | +56.0% |
| 2015 | $10.4K | -44.7% |
| 2014 | $18.8K | -82.9% |
| 2013 | $110.0K | -73.0% |
| 2012 | $407.7K | +4.4% |
| 2011 | $390.6K | -46.7% |
| 2010 | $733.4K | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2024 | $0.00 | — | — |
| June 30, 2024 | $0.00 | — | — |
| March 31, 2024 | $0.00 | -100.0% | — |
| September 30, 2023 | $0.00 | — | — |
| June 30, 2023 | $0.00 | — | -100.0% |
| March 31, 2023 | $250.0K | — | — |
| September 30, 2022 | $0.00 | — | — |
| June 30, 2022 | $0.00 | — | — |
- PALISADE BIO, INC. showed a decrease of -100.0% in Total Revenue compared to the prior fiscal year.
- Over the 2010–2024 period, PALISADE BIO, INC.’s total revenue has declined by 100.0% (from $733.4 thousand to $0.00).
- The most recent figure is from PALISADE BIO, INC.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 24, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: